The NIH Microphysiological Systems Program: Tissue on Chips for Safety, Efficacy, and Precision Medicine Studies
Explore innovative tissue chip technology for drug development, addressing limitations in current safety and efficacy prediction methods to improve human clinical trial outcomes.
臨床研究者のための生物統計学 - 統計家の行動基準と臨床試験の実施
Discover 臨床試験の倫理性と科学性のバランス、人体実験の歴史的背景から最新の規制まで、医療研究における試験デザインの重要性と実施条件を深く理解する
Open-Source Science: Working with OSPOs to Accelerate Research in Health and Sustainability
Explore how Open-Source Science accelerates research in health and sustainability through community support, ecosystem mapping, and gap identification in scientific software development.
Promise and Perils of Artificial Intelligence in Healthcare
Explore AI's transformative impact on healthcare, from disease detection to personalized treatments, while examining ethical concerns and the irreplaceable human touch in patient care.
What Really Happens When You Mix Medications?
Explore how machine learning in drug development helps uncover adverse effects of medication interactions, revolutionizing our understanding of pharmaceutical safety.
Can Medical Industry and Medical Research Live Happily Ever After?
Explore the potential for collaboration between academic medical research and the pharmaceutical industry to accelerate drug development and improve patient outcomes.
Leadership Conversation With Pablo Legoretta - TED
Explore the future of life science financing and drug development with insights on research models, public awareness, and potential health securitization.
Deep Dive - Artificial Intelligence on the Rise
Explore AI's transformative impact on healthcare, from diagnosis to cost reduction, and its potential in developing countries. Experts discuss opportunities, risks, and ethical considerations.
A Journey to the Cutting Edge of Bioscience - Cancer as a Case Study
Explore cutting-edge bioscience advancements in cancer care, discussing achievements, barriers, and future discoveries. Experts examine data sharing, research collaboration, and innovative technologies shaping oncology's landscape.
AI and Machine Learning in Cancer Medicine
Explore AI and machine learning's impact on cancer detection, diagnosis, drug development, and clinical decision-making, discussing potential benefits and challenges in oncology.
Antibiotic Bootcamp - How Does a Molecule Become a Physical Medicine to be Given to a Human
Explore the journey of transforming a molecule into medicine, covering chemistry, manufacturing, and controls. Experts discuss challenges, processes, and regulatory aspects of antibiotic development.
New Single-Dose Influenza Drug
Explore the latest single-dose influenza drug through phase 2 and 3 clinical trials, examining its safety, efficacy, and potential impact on symptom relief and viral shedding within 48 hours of onset.
New Targets for SARS - MERS Drugs
Explore new drug targets for SARS and MERS coronaviruses, including a promising compound and potential treatments, with insights from leading researchers in the field.
Cancer's Last Stand - The Genome Solution
Experts discuss The Cancer Genome Atlas, exploring how genomic research is revolutionizing cancer understanding and treatment, with insights on breakthroughs, collaborations, and future implications for healthcare and drug development.
くすりの体内動態とその制御 - チャプター2
薬の体内での動きと制御メカニズムについて、京都大学薬学部の専門的な知見から学ぶ模擬講義の第2章を探求する。
Monoclonal Antibody-Based Therapeutics for New Variants of Emerging Viruses
Explore monoclonal antibody-based therapeutics for emerging virus variants, focusing on development strategies and potential applications in combating evolving pathogens.
How AI Could Transform Human Health - Benefits and Risks
Experts discuss AI's potential to revolutionize healthcare, from drug development to diagnostics, while addressing ethical concerns and governance challenges for responsible implementation.
AI-Assisted Automated Chemical Synthesis Planning and Execution
Explore AI-driven chemical synthesis planning integrated with robotic automation, streamlining complex molecule production for drug development and materials science.
Enabling Faster Therapeutic Antibody Discovery Through AI/ML-Wet Lab Integration
Explore AI/ML-guided antibody design for faster, more effective therapeutic discovery using an integrated platform that combines high-speed wet lab with advanced automation.
GLP-1 Agonists - Wonder Drugs of the 21st Century?
Explore the potential of GLP-1 agonists in treating diabetes, obesity, and beyond. Discuss their mechanisms, future applications, and accessibility challenges in this cutting-edge medical field.
Drug Development in Oncology - Opportunities, Challenges and Mechanistic Modeling - Lecture 1
Explore opportunities and challenges in oncology drug development, focusing on mechanistic approaches to enhance treatment efficacy and overcome resistance in cancer therapy.